ArticleJournal of cancer survivorship : research and practice2026
Patient-reported duplication and missed breast cancer survivorship care more than 5 years after initial treatment.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
purposeLittle is known about the long-term coordination of breast cancer survivorship care, including duplicated and/or missed care and whether disparities exist. We investigated patients' perceptions of survivorship care coordination more than 5 years post-initial treatment, and examined differences by survivorship care delivery model, and patient characteristics.
methodsThe iCanCare study is a longitudinal study of women diagnosed with early-stage breast cancer in 2014-2015 identified in the Los Angeles and Georgia Surveillance, Epidemiology and End Results registries. Women were surveyed during initial treatment and again 6-7 years later (2021-2022) (N = 1412, 60% response rate). Respondents were asked how often survivorship services were ordered twice (duplication) or key aspects of care were missed, and who led their care delivery. Associations of participant characteristics and survivorship care delivery model with duplication and missed care were estimated using multivariable logistic regression.
resultsOverall, 29% of participants reported duplication, and 30% reported missed survivorship care. Latina women (vs. white) and those with 2 or more comorbidities (vs. 0) were more likely to report duplicated care (aOR: 1.71, 95% CI: 1.04-2.80, comorbidities aOR: 2.04, 1.27, 3.26). Women who reported oncologist-led care (vs. PCP-led) were more likely to report duplicated care (aOR: 2.17, 1.40-3.35) but were less likely to report missed care (aOR: 0.62, 0.42, 0.93).
conclusionA notable proportion of long-term breast cancer survivors reported duplicated and/or missed survivorship care, with Latina women more often reporting duplicated care. IMPLICATIONS FOR CANCER SURVIVORS: These findings highlight persistent challenges of coordinating long-term survivorship care and the need for scalable strategies and incentives to promote coordination across oncology and primary care teams.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.